149 related articles for article (PubMed ID: 6692480)
1. Lysis of herpes simplex virus-infected targets. II. Nature of the effector cells.
Hendricks RL; Sugar J
Cell Immunol; 1984 Feb; 83(2):262-70. PubMed ID: 6692480
[TBL] [Abstract][Full Text] [Related]
2. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):208-13. PubMed ID: 3972502
[TBL] [Abstract][Full Text] [Related]
3. Lysis of herpes simplex virus (HSV) infected targets. I. A comparison of the activity of lymphocytes from patients with HSV recurrences at different anatomical sites.
Hendricks RL; Sugar J
Curr Eye Res; 1984 Mar; 3(3):473-80. PubMed ID: 6321105
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
5. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
6. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
7. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells.
Howell DM; Fitzgerald-Bocarsly P
Immunology; 1991 Mar; 72(3):443-7. PubMed ID: 1851136
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1987 Sep; 108(2):313-22. PubMed ID: 3113742
[TBL] [Abstract][Full Text] [Related]
10. Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines.
Leibson PJ; Hunter-Laszlo M; Douvas GS; Hayward AR
J Clin Immunol; 1986 May; 6(3):216-24. PubMed ID: 3013922
[TBL] [Abstract][Full Text] [Related]
11. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
Muñoz A; Carrasco L; Fresno M
J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults.
Abo T; Miller CA; Balch CM
Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709
[TBL] [Abstract][Full Text] [Related]
15. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):201-7. PubMed ID: 2579040
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells in the blood and bone marrow of the rhesus monkey.
Gengozian N; Longley RE; Filler J; Good RA
Cell Immunol; 1986 Aug; 101(1):24-38. PubMed ID: 3742605
[TBL] [Abstract][Full Text] [Related]
18. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
19. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
Fitzgerald PA; Mendelsohn M; Lopez C
J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
[TBL] [Abstract][Full Text] [Related]
20. Leu 7+ (HNK-1+) cells. II. Characterization of blood Leu 7+ cells with respect to immunophenotype and cell density.
Porwit-Ksiazek A; Aman P; Ksiazek T; Biberfeld P
Scand J Immunol; 1983 Dec; 18(6):495-9. PubMed ID: 6229871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
